Guerbet is a French pharmaceutical group that has been supporting healthcare professionals specialized in diagnostic and interventional imaging since 1926. Guerbet develops and markets contrast media, delivery systems, medical devices, and related solutions adapted to their needs.
By caring for people
By focusing on patient outcomes
By continuously providing innovative solutions
By daring to make bold choices
By advancing through knowledge-sharing
This our purpose
It all began with Marcel Guerbet’s discovery of the first iodinated organic contrast medium in 1901. The company was later founded in 1926 by André Guerbet. Guerbet’s innovative workforce has since left its mark on medical imaging technologies and contrast media, taking the company to the next level. Today, Guerbet sells a comprehensive range of products suitable for X-Ray and Magnetic Resonance Imaging (MRI).
Guerbet recently launched a strategic initiative to develop a new business based on digital technologies and artificial intelligence with two objectives: first, to improve the productivity of radiologists, e.g. with diagnostic assistance tools, and second, to obtain a tumor tissue characterization through imaging to better guide treatments or even eventually replace a biopsy.